Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 8 | 2002 | 251 | 0.650 |
Why?
|
| Alzheimer Disease | 12 | 2009 | 560 | 0.600 |
Why?
|
| Neuropsychological Tests | 7 | 2002 | 353 | 0.570 |
Why?
|
| Cognition | 3 | 2002 | 466 | 0.270 |
Why?
|
| Social Behavior Disorders | 2 | 1996 | 6 | 0.210 |
Why?
|
| Presenilin-1 | 5 | 2009 | 58 | 0.190 |
Why?
|
| Sick Role | 1 | 2001 | 15 | 0.190 |
Why?
|
| Mental Recall | 2 | 1998 | 94 | 0.170 |
Why?
|
| Anxiety Disorders | 1 | 2001 | 190 | 0.160 |
Why?
|
| Amobarbital | 1 | 1999 | 2 | 0.160 |
Why?
|
| Epilepsies, Partial | 1 | 1999 | 18 | 0.160 |
Why?
|
| Geriatric Assessment | 2 | 1996 | 165 | 0.150 |
Why?
|
| Intelligence | 1 | 1998 | 56 | 0.150 |
Why?
|
| Depressive Disorder | 1 | 2001 | 292 | 0.150 |
Why?
|
| Aged | 18 | 2012 | 13595 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2009 | 215 | 0.130 |
Why?
|
| Aging | 3 | 1998 | 731 | 0.130 |
Why?
|
| Activities of Daily Living | 2 | 1996 | 301 | 0.130 |
Why?
|
| Memory, Short-Term | 1 | 1996 | 59 | 0.130 |
Why?
|
| Genes, Dominant | 1 | 1996 | 55 | 0.130 |
Why?
|
| Life Tables | 2 | 1996 | 24 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 1996 | 163 | 0.110 |
Why?
|
| Heterozygote | 3 | 2009 | 163 | 0.100 |
Why?
|
| Subthalamus | 1 | 2012 | 1 | 0.100 |
Why?
|
| Pedigree | 2 | 2007 | 184 | 0.100 |
Why?
|
| Mutation | 6 | 2009 | 2466 | 0.100 |
Why?
|
| Subthalamic Nucleus | 1 | 2012 | 14 | 0.100 |
Why?
|
| Limbic System | 1 | 2012 | 27 | 0.100 |
Why?
|
| Mood Disorders | 1 | 2012 | 69 | 0.090 |
Why?
|
| Deep Brain Stimulation | 1 | 2012 | 64 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2007 | 75 | 0.090 |
Why?
|
| Adult | 13 | 2009 | 15971 | 0.090 |
Why?
|
| Male | 16 | 2012 | 27950 | 0.090 |
Why?
|
| Middle Aged | 14 | 2012 | 16541 | 0.090 |
Why?
|
| Female | 15 | 2012 | 31225 | 0.080 |
Why?
|
| Humans | 22 | 2012 | 60079 | 0.080 |
Why?
|
| Amyloid | 2 | 2007 | 63 | 0.080 |
Why?
|
| Cholesterol | 1 | 2009 | 255 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 2 | 2007 | 194 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 1099 | 0.070 |
Why?
|
| Peptide Fragments | 2 | 2007 | 353 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 2007 | 93 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 908 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2005 | 1036 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2012 | 1175 | 0.060 |
Why?
|
| Psychometrics | 3 | 1992 | 359 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2007 | 5200 | 0.050 |
Why?
|
| Institutionalization | 2 | 1996 | 23 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 219 | 0.050 |
Why?
|
| Brain | 2 | 2005 | 1485 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2005 | 677 | 0.050 |
Why?
|
| ROC Curve | 1 | 2002 | 260 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2001 | 50 | 0.050 |
Why?
|
| Probability | 1 | 2001 | 173 | 0.040 |
Why?
|
| Electroencephalography | 2 | 1999 | 138 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2002 | 1565 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 1999 | 20 | 0.040 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1999 | 19 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 1999 | 59 | 0.040 |
Why?
|
| Functional Laterality | 1 | 1999 | 133 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 1996 | 2360 | 0.040 |
Why?
|
| Mass Screening | 1 | 2002 | 662 | 0.030 |
Why?
|
| Perceptual Disorders | 1 | 1996 | 8 | 0.030 |
Why?
|
| Visual Perception | 1 | 1996 | 41 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1996 | 93 | 0.030 |
Why?
|
| Reaction Time | 1 | 1996 | 119 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 1996 | 125 | 0.030 |
Why?
|
| Schizophrenia | 1 | 1996 | 250 | 0.030 |
Why?
|
| Apolipoproteins E | 2 | 2009 | 98 | 0.030 |
Why?
|
| Survival Rate | 1 | 1996 | 793 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 1998 | 6147 | 0.030 |
Why?
|
| Research Design | 1 | 1996 | 569 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1992 | 10 | 0.020 |
Why?
|
| Behavior | 1 | 1992 | 37 | 0.020 |
Why?
|
| Individuality | 1 | 1992 | 21 | 0.020 |
Why?
|
| Age Factors | 1 | 1996 | 1527 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1992 | 386 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2012 | 113 | 0.020 |
Why?
|
| Fecal Incontinence | 1 | 1990 | 27 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2012 | 268 | 0.020 |
Why?
|
| Neurons | 1 | 1996 | 861 | 0.020 |
Why?
|
| Urinary Incontinence | 1 | 1990 | 39 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1996 | 2480 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 9 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 2009 | 21 | 0.020 |
Why?
|
| Simvastatin | 1 | 2009 | 28 | 0.020 |
Why?
|
| Educational Status | 1 | 1990 | 273 | 0.020 |
Why?
|
| Pyrroles | 1 | 2009 | 50 | 0.020 |
Why?
|
| Dementia, Multi-Infarct | 1 | 1988 | 4 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 1988 | 18 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 1990 | 679 | 0.020 |
Why?
|
| Aggression | 1 | 1988 | 56 | 0.020 |
Why?
|
| Age of Onset | 2 | 2000 | 168 | 0.020 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 35 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2005 | 847 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2000 | 576 | 0.020 |
Why?
|
| Violence | 1 | 1988 | 149 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 174 | 0.020 |
Why?
|
| Prognosis | 1 | 1990 | 1591 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 930 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1990 | 1471 | 0.020 |
Why?
|
| Family Health | 1 | 2005 | 68 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1996 | 5266 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 190 | 0.010 |
Why?
|
| tau Proteins | 1 | 2005 | 103 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2005 | 131 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 306 | 0.010 |
Why?
|
| Memory | 2 | 1996 | 118 | 0.010 |
Why?
|
| Disease Progression | 1 | 2005 | 1053 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1988 | 770 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2000 | 20 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 3621 | 0.010 |
Why?
|
| Phenotype | 1 | 2000 | 1145 | 0.010 |
Why?
|
| Motion Perception | 1 | 1996 | 5 | 0.010 |
Why?
|
| Form Perception | 1 | 1996 | 5 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1996 | 19 | 0.010 |
Why?
|
| Space Perception | 1 | 1996 | 19 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1996 | 15 | 0.010 |
Why?
|
| Neurites | 1 | 1996 | 22 | 0.010 |
Why?
|
| Neurofibrillary Tangles | 1 | 1996 | 10 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 27 | 0.010 |
Why?
|
| Schizophrenic Psychology | 1 | 1996 | 65 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1996 | 91 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1996 | 129 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 179 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 1996 | 112 | 0.010 |
Why?
|
| Cerebellum | 1 | 1996 | 93 | 0.010 |
Why?
|
| Alleles | 1 | 1996 | 417 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1992 | 17 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1992 | 26 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1992 | 134 | 0.010 |
Why?
|
| Outpatients | 1 | 1992 | 140 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 483 | 0.010 |
Why?
|
| Learning | 1 | 1992 | 172 | 0.010 |
Why?
|
| Caregivers | 1 | 1992 | 232 | 0.010 |
Why?
|
| Nursing Homes | 1 | 1992 | 672 | 0.000 |
Why?
|